Suppr超能文献

携带结肠腺癌的小鼠肿瘤组织和宿主组织中的脂肪生成

Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas.

作者信息

Mulligan H D, Tisdale M J

机构信息

Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.

出版信息

Br J Cancer. 1991 May;63(5):719-22. doi: 10.1038/bjc.1991.162.

Abstract

Although animals bearing the MAC16 colon adenocarcinoma showed progressive weight loss, the average food consumption (15.1 +/- 0.6 Kcal day-1) did not differ from non tumour-bearing controls (15.3 +/- 0.3 Kcal day-1), while animals bearing a related colon adenocarcinoma, MAC13, which had no effect on body weight had a significantly (P less than 0.01) elevated food intake (16.4 +/- 0.3 Kcal day-1) above controls. Weight loss in animals bearing the MAC16 tumour was associated with a significant reduction in the percentage contribution of the kidneys, colon and epididymal fat pads to the total body weight. Although loss of body fat occurred only in the MAC16 model, both tumours were capable of synthesising lipids from glucose both in vitro and in vivo at the same rate. In addition both tumours increased the rate of lipogenesis from glucose in kidney, liver and epididymal fat pads of the host. Lipogenesis from glucose would be expected to result in a loss of utilisable carbohydrate energy and thus would be expected to increase the overall energy requirements in the tumour-bearing state leading to catabolism of host body tissues if the energy intake is not increased.

摘要

尽管携带MAC16结肠腺癌的动物体重逐渐减轻,但平均食物消耗量(15.1±0.6千卡/天)与未患肿瘤的对照组(15.3±0.3千卡/天)并无差异,而携带相关结肠腺癌MAC13的动物对体重没有影响,但其食物摄入量(16.4±0.3千卡/天)显著高于对照组(P<0.01)。携带MAC16肿瘤的动物体重减轻与肾脏、结肠和附睾脂肪垫占总体重的百分比显著降低有关。虽然只有在MAC16模型中出现了体脂减少,但两种肿瘤在体外和体内均能以相同速率将葡萄糖合成脂质。此外,两种肿瘤均提高了宿主肾脏、肝脏和附睾脂肪垫中由葡萄糖生成脂肪的速率。由葡萄糖生成脂肪预计会导致可利用碳水化合物能量的损失,因此,如果不增加能量摄入,预计会增加荷瘤状态下的总体能量需求,导致宿主体组织的分解代谢。

相似文献

1
Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas.
Br J Cancer. 1991 May;63(5):719-22. doi: 10.1038/bjc.1991.162.
2
Lipid metabolism in cancer cachexia.
Br J Cancer. 1992 Jul;66(1):57-61. doi: 10.1038/bjc.1992.216.
3
Metabolic substrate utilization by tumour and host tissues in cancer cachexia.
Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):321-6. doi: 10.1042/bj2770321.
4
Reduction of weight loss and tumour size in a cachexia model by a high fat diet.
Br J Cancer. 1987 Jul;56(1):39-43. doi: 10.1038/bjc.1987.149.
5
Changes in host liver fatty acid synthase in tumour-bearing mice.
Cancer Lett. 1988 Nov;42(3):231-5. doi: 10.1016/0304-3835(88)90310-2.
7
Catabolic factors in cancer cachexia.
In Vivo. 1996 Mar-Apr;10(2):131-6.
8
Metabolic substrate utilization by a tumour cell line which induces cachexia in vivo.
Br J Cancer. 1986 Oct;54(4):601-6. doi: 10.1038/bjc.1986.215.

引用本文的文献

2
Cancer cachexia: biomarkers and the influence of age.
Mol Oncol. 2024 Sep;18(9):2070-2086. doi: 10.1002/1878-0261.13590. Epub 2024 Feb 27.
3
Tricarboxylic acid (TCA) cycle, sphingolipid, and phosphatidylcholine metabolism are dysregulated in infection-induced cachexia.
Heliyon. 2023 Jul 5;9(7):e17411. doi: 10.1016/j.heliyon.2023.e17411. eCollection 2023 Jul.
4
Energy metabolism in cachexia.
EMBO Rep. 2019 Apr;20(4). doi: 10.15252/embr.201847258. Epub 2019 Mar 19.
5
Adipose tissue: between the extremes.
EMBO J. 2017 Jul 14;36(14):1999-2017. doi: 10.15252/embj.201696206. Epub 2017 Jun 16.
6
The role of triglyceride lipases in cancer associated cachexia.
Trends Mol Med. 2013 May;19(5):292-301. doi: 10.1016/j.molmed.2013.02.006. Epub 2013 Mar 14.
8
Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.
Br J Cancer. 2002 Aug 27;87(5):580-4. doi: 10.1038/sj.bjc.6600493.
9
Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma.
Mol Cell Biochem. 1996 Dec 6;165(1):17-23. doi: 10.1007/BF00229741.
10
Humoral mediation for cachexia in tumour-bearing rats.
Br J Cancer. 1993 Jan;67(1):15-23. doi: 10.1038/bjc.1993.4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验